Article Text

PDF
Bisolvon and bisolvomycin up to date

Abstract

Two years ago we concluded that after oral administration bromhexine (Bisolvon) disrupted mucopolysaccharide fibres in mucoid bronchial secretions, changing their flow properties, but that its value in chronic bronchitis, asthma or emphysema remained in doubt.1 Since then more reports on the drug have appeared, and the makers now claim that Bisolvon helps chronic bronchitics ‘by thinning sputum, easing expectoration, improving pulmonary function and producing clinical improvement’.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.